S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stenocare A/S
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Other Receivables
kr1.5m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Other Receivables
kr13.3B
CAGR 3-Years
34%
CAGR 5-Years
27%
CAGR 10-Years
9%
H Lundbeck A/S
CSE:HLUN A
Other Receivables
kr661m
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Other Receivables
kr108m
CAGR 3-Years
-8%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Other Receivables?
Other Receivables
1.5m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Other Receivables amounts to 1.5m DKK.

What is Stenocare A/S's Other Receivables growth rate?
Other Receivables CAGR 3Y
5%

Over the last year, the Other Receivables growth was -42%. The average annual Other Receivables growth rates for Stenocare A/S have been 5% over the past three years .

Back to Top